Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
DexCom (DXCM) PT Raised to $140 at Jefferies
February 10, 2023 8:13 AM ESTJefferies analyst Matthew Taylor raised the price target on DexCom (NASDAQ: DXCM) to $140.00 (from $135.00) while maintaining a Buy rating following earnings.
The analyst commented, "DXCM reported 4Q sales of $815.2MM +20% organic, and reiterated guidance for the year. As a reminder, DXCM... More
DexCom (DXCM) Tops Q4 EPS by 7c
February 9, 2023 4:06 PM ESTDexCom (NASDAQ: DXCM) reported Q4 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2 million versus the consensus estimate of $809.35 million.
GUIDANCE:
DexCom sees Q1 2023 revenue of $3.35-3.49 billion, versus the consensus of $3.47... More
